212 related articles for article (PubMed ID: 36376513)
1. Adaptive activation of EFNB2/EPHB4 axis promotes post-metastatic growth of colorectal cancer liver metastases by LDLR-mediated cholesterol uptake.
Xu C; Gu L; Kuerbanjiang M; Jiang C; Hu L; Liu Y; Xue H; Li J; Zhang Z; Xu Q
Oncogene; 2023 Jan; 42(2):99-112. PubMed ID: 36376513
[TBL] [Abstract][Full Text] [Related]
2. Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions.
Xiong C; Wen Y; Zhao J; Yin D; Xu L; Chelariu-Raicu A; Yao C; Leng X; Liu J; Chaudhari RR; Zhang S; Sood AK; Li C
Sci Rep; 2020 Jan; 10(1):520. PubMed ID: 31949258
[TBL] [Abstract][Full Text] [Related]
3. Upregulated EFNB2 and EPHB4 promotes lung development in a nitrofen-induced congenital diaphragmatic hernia rat model.
Liu H; Li X; Yu WQ; Liu CX
Int J Mol Med; 2018 Nov; 42(5):2373-2382. PubMed ID: 30106123
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes occur in patterns of endometrial EFNB2/EPHB4 expression during the period of spiral arterial modification in mice.
Zhang J; Dong H; Wang B; Zhu S; Croy BA
Biol Reprod; 2008 Sep; 79(3):450-8. PubMed ID: 18463357
[TBL] [Abstract][Full Text] [Related]
5. A synthetic bivalent peptide ligand of EphB4 with potent agonistic activity.
Fan T; Liang B; Nie L; Wang J; Zhang H; Ciechanover A; Xu Y; An J; Huang Z
Eur J Med Chem; 2022 Dec; 244():114804. PubMed ID: 36208510
[TBL] [Abstract][Full Text] [Related]
6. DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.
Alam SK; Yadav VK; Bajaj S; Datta A; Dutta SK; Bhattacharyya M; Bhattacharya S; Debnath S; Roy S; Boardman LA; Smyrk TC; Molina JR; Chakrabarti S; Chowdhury S; Mukhopadhyay D; Roychoudhury S
Cell Death Differ; 2016 Apr; 23(4):707-22. PubMed ID: 26494468
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
[No Abstract] [Full Text] [Related]
9. Role of EFNB2/EPHB4 signaling in spiral artery development during pregnancy: An appraisal.
Dong H; Yu C; Mu J; Zhang J; Lin W
Mol Reprod Dev; 2016 Jan; 83(1):12-8. PubMed ID: 26501487
[TBL] [Abstract][Full Text] [Related]
10. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
Liersch-Löhn B; Slavova N; Buhr HJ; Bennani-Baiti IM
Int J Cancer; 2016 Mar; 138(5):1220-31. PubMed ID: 26414866
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
12. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of ephrinB2 in periodontal ligament stem cells (PDLSCs) modulates osteogenic differentiation via signaling crosstalk between ephrinB2 and EphB4 in PDLSCs and between PDLSCs and pre-osteoblasts within co-culture.
Zhu SY; Wang PL; Liao CS; Yang YQ; Yuan CY; Wang S; Dissanayaka WL; Heng BC; Zhang CF
J Periodontal Res; 2017 Jun; 52(3):562-573. PubMed ID: 27763659
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of
Ni Q; Chen P; Zhu B; Li J; Xie D; Ma X
Oncol Lett; 2020 Jan; 19(1):917-929. PubMed ID: 31885720
[TBL] [Abstract][Full Text] [Related]
15. EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer.
Lv J; Xia Q; Wang J; Shen Q; Zhang J; Zhou X
Exp Mol Pathol; 2016 Jun; 100(3):402-8. PubMed ID: 27072105
[TBL] [Abstract][Full Text] [Related]
16. Generation of transgenic mice overexpressing EfnB2 in endothelial cells.
Luxey M; Laussu J; Jungas T; Davy A
Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation.
Wang C; Li P; Xuan J; Zhu C; Liu J; Shan L; Du Q; Ren Y; Ye J
Cell Physiol Biochem; 2017; 42(2):729-742. PubMed ID: 28618417
[TBL] [Abstract][Full Text] [Related]
18. Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk.
Wang Y; Hamet P; Thorin E; Tremblay J; Raelson J; Wu Z; Luo H; Jin W; Lavoie JL; Peng J; Marois-Blanchet FC; Tahir MR; Chalmers J; Woodward M; Harrap S; Qi S; Li CY; Wu J
Eur J Hum Genet; 2016 Dec; 24(12):1817-1825. PubMed ID: 27530629
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab.
Guijarro-Muñoz I; Sánchez A; Martínez-Martínez E; García JM; Salas C; Provencio M; Alvarez-Vallina L; Sanz L
Med Oncol; 2013; 30(2):572. PubMed ID: 23579861
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.
Sasine JP; Kozlova NY; Valicente L; Dukov J; Tran DH; Himburg HA; Kumar S; Khorsandi S; Chan A; Grohe S; Li M; Kan J; Sehl ME; Schiller GJ; Reinhardt B; Singh BK; Ho R; Yue P; Pasquale EB; Chute JP
Cancer Res; 2024 Mar; 84(6):919-934. PubMed ID: 38231476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
